Dopaminergic receptors in the anterior pituitary gland. Correlation of [3H]dihydroergocryptine binding with the dopaminergic control of prolactin release. 1978

M G Caron, and M Beaulieu, and V Raymond, and B Gagné, and J Drouin, and R J Lefkowitz, and F Labrie

UI MeSH Term Description Entries
D007700 Kinetics The rate dynamics in chemical or physical systems.
D010903 Pituitary Gland, Anterior The anterior glandular lobe of the pituitary gland, also known as the adenohypophysis. It secretes the ADENOHYPOPHYSEAL HORMONES that regulate vital functions such as GROWTH; METABOLISM; and REPRODUCTION. Adenohypophysis,Anterior Lobe of Pituitary,Anterior Pituitary Gland,Lobus Anterior,Pars Distalis of Pituitary,Adenohypophyses,Anterior Pituitary Glands,Anterior, Lobus,Anteriors, Lobus,Lobus Anteriors,Pituitary Anterior Lobe,Pituitary Glands, Anterior,Pituitary Pars Distalis
D011388 Prolactin A lactogenic hormone secreted by the adenohypophysis (PITUITARY GLAND, ANTERIOR). It is a polypeptide of approximately 23 kD. Besides its major action on lactation, in some species prolactin exerts effects on reproduction, maternal behavior, fat metabolism, immunomodulation and osmoregulation. Prolactin receptors are present in the mammary gland, hypothalamus, liver, ovary, testis, and prostate. Lactogenic Hormone, Pituitary,Mammotropic Hormone, Pituitary,Mammotropin,PRL (Prolactin),Hormone, Pituitary Lactogenic,Hormone, Pituitary Mammotropic,Pituitary Lactogenic Hormone,Pituitary Mammotropic Hormone
D011954 Receptors, Dopamine Cell-surface proteins that bind dopamine with high affinity and trigger intracellular changes influencing the behavior of cells. Dopamine Receptors,Dopamine Receptor,Receptor, Dopamine
D002462 Cell Membrane The lipid- and protein-containing, selectively permeable membrane that surrounds the cytoplasm in prokaryotic and eukaryotic cells. Plasma Membrane,Cytoplasmic Membrane,Cell Membranes,Cytoplasmic Membranes,Membrane, Cell,Membrane, Cytoplasmic,Membrane, Plasma,Membranes, Cell,Membranes, Cytoplasmic,Membranes, Plasma,Plasma Membranes
D004088 Dihydroergotoxine A mixture of three different hydrogenated derivatives of ERGOTAMINE: DIHYDROERGOCORNINE; DIHYDROERGOCRISTINE; and DIHYDROERGOCRYPTINE. Dihydroergotoxine has been proposed to be a neuroprotective agent and a nootropic agent. The mechanism of its therapeutic actions is not clear, but it can act as an alpha-adrenergic antagonist and a dopamine agonist. The methanesulfonate salts of this mixture of alkaloids are called ERGOLOID MESYLATES. Co-Dergocrine,Ergot Alkaloids, Hydrogenated,Dihydroergotoxin,Alkaloids, Hydrogenated Ergot,Hydrogenated Ergot Alkaloids
D005260 Female Females
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D001667 Binding, Competitive The interaction of two or more substrates or ligands with the same binding site. The displacement of one by the other is used in quantitative and selective affinity measurements. Competitive Binding
D013329 Structure-Activity Relationship The relationship between the chemical structure of a compound and its biological or pharmacological activity. Compounds are often classed together because they have structural characteristics in common including shape, size, stereochemical arrangement, and distribution of functional groups. Relationship, Structure-Activity,Relationships, Structure-Activity,Structure Activity Relationship,Structure-Activity Relationships

Related Publications

M G Caron, and M Beaulieu, and V Raymond, and B Gagné, and J Drouin, and R J Lefkowitz, and F Labrie
December 1980, Endocrinology,
M G Caron, and M Beaulieu, and V Raymond, and B Gagné, and J Drouin, and R J Lefkowitz, and F Labrie
November 1982, Canadian journal of biochemistry,
M G Caron, and M Beaulieu, and V Raymond, and B Gagné, and J Drouin, and R J Lefkowitz, and F Labrie
January 1999, Regulatory peptides,
M G Caron, and M Beaulieu, and V Raymond, and B Gagné, and J Drouin, and R J Lefkowitz, and F Labrie
February 1982, Endocrinology,
M G Caron, and M Beaulieu, and V Raymond, and B Gagné, and J Drouin, and R J Lefkowitz, and F Labrie
February 1980, Life sciences,
M G Caron, and M Beaulieu, and V Raymond, and B Gagné, and J Drouin, and R J Lefkowitz, and F Labrie
August 1997, Doklady Akademii nauk,
M G Caron, and M Beaulieu, and V Raymond, and B Gagné, and J Drouin, and R J Lefkowitz, and F Labrie
June 1985, Neuroendocrinology,
M G Caron, and M Beaulieu, and V Raymond, and B Gagné, and J Drouin, and R J Lefkowitz, and F Labrie
June 1982, Journal of neurochemistry,
M G Caron, and M Beaulieu, and V Raymond, and B Gagné, and J Drouin, and R J Lefkowitz, and F Labrie
March 1978, The Journal of pharmacology and experimental therapeutics,
M G Caron, and M Beaulieu, and V Raymond, and B Gagné, and J Drouin, and R J Lefkowitz, and F Labrie
August 1977, Brain research,
Copied contents to your clipboard!